By proceeding, you agree to our Terms of Use and Privacy Policy.
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer.
30-01 April 2022
Advance the Development of NK, Gamma-Delta T, Macrophage, and NKT Cell Therapies to Develop Cost-Effective Treatments for Liquid and Solid Tumors 2021 has been a game-changing year for the NK cell community. Positive clinical results have forced the
Event Ended
USA
Paid
San Diego
28-30 March 2023
Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics.